N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine

We are N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine CAS:116169-90-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 116169-90-5
Product Name: N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine
Other Name:
N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine
(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid
 
Density: 1.234 g/cm3
Boiling Point: 586.987ºC at 760 mmHg
Melting Point: 134-136ºC
Molecular Formula: C20H27F3N2O5
Molecular Weight: 432.43400
Flash Point: 308.799ºC
Exact Mass: 432.18700
PSA: 104.73000
LogP: 3.22430
Index of Refraction: 1.495
Storage condition: -20ºC Freezer
 
Specification
Appearance: White or off-white crystalline powder
Assay: 98.5-102.0%
Specific rotation: +6°~+9°
Loss on drying: ≤1.0%
Single largest impurity: ≤1.0%
Total impurities: ≤2.0%
 
Application
Intermediates of Lisinopril CAS: 76547-98-3.
Be used as pharmaceutical intermediate, mainly used to synthesize antihypertensive drug Lisinopril.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N2-(S)-1-Ethoxycarbonyl-3-phenylpropyl-N8-trifluoroacetyl-L-lysine


Related News: We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally.10-(3-(naphthalen-2-yl)phenyl)anthracene-9-boronic acid We purchase the raw materials from raw material or chemical product manufacturers both in Japan and internationally.4,6-dibromothieno[3,4-c]furan-1,3-dione CAS:1015423-45-6 A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.6-methyl-5-nitropyridin-2-amine CAS:22280-62-2 A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.

Related Products
Product Name
5-(4-bromophenyl)-4,6-dichloropyrimidine View Details
Methyl 5-Formyl-2-methoxybenzoate View Details
(1-Hydroxycyclohexyl)(4-methoxyphenyl)acetonitrile View Details
3-Bromo-4-fluorotoluene manufacturer Phenyl Vinyl Sulfone manufacturer 4-Bromo-2,6-difluoroanisole manufacturer Diethoxymethylphenylsilane manufacturer Z-β-ALA-OSU manufacturer